Rahul Mannan
University of Michigan
H-index: 20
North America-United States
Top articles of Rahul Mannan
Suggested searches
Perspective
2024/3/4
Sunkyung Kim
H-Index: 2
Jing Chen
H-Index: 7
Shuyan Sun
H-Index: 13
Xin Huang
H-Index: 34
Li Yan
H-Index: 4
Takuya Noguchi
H-Index: 21
Atsushi Matsuzawa
H-Index: 36
Ji-Young Kim
H-Index: 9
Sanghoon Kim
H-Index: 5
Ziyun Zhang
H-Index: 3
Qiang Sun
H-Index: 9
Jiali Jiang
H-Index: 5
Xinzhou Li
H-Index: 4
Jacob Freeman
H-Index: 10
Erick Robinson
H-Index: 13
Darcy Bird
H-Index: 2
Yeji Choi
H-Index: 3
Federico Caporaletti
H-Index: 3
Antoine Deblais
H-Index: 7
Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS)
Medical Oncology
2024/3
Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients—A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations …
The American journal of surgical pathology
2024/2/1
Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Nature
2024/4/22
Abstract A034: Development of a novel class of genomic biomarkers through mathematical modeling of cancer genome contiguity
Cancer Research
2024/1/9
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
Proceedings of the National Academy of Sciences
2024/4/9
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer
bioRxiv
2024/3/30
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
Neoplasia
2024/1/6
Genome instability in renal tumors
Cancer Research
2024/3/22
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer
bioRxiv
2024
Deletion of the lipid kinase PIKfyve in Kras-driven pancreatic genetically engineered mouse model
Cancer Research
2024/3/22
Pan-tissue master regulator inference reveals mechanisms of MHC alterations in cancers
Cancer Research
2024/3/22
CDK12 Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality
bioRxiv
2024
Targeting AR positive prostate cancer cells by the novel P300/CBP oral available PROTAC degrader
Cancer Research
2024/3/22
Harnessing PIKfyve as a therapeutic vulnerability in neuroendocrine prostate cancer
Cancer Research
2024/3/22
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis
bioRxiv
2024/1/1
Targeting the SWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies
Cancer Research
2024/3/22
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven Malignancies
bioRxiv
2024
FOXA1 alterations distinctively drive prostate tumorigenesis or therapy resistance in mice
Cancer Research
2024/3/22
Targeting lipid metabolism in pancreatic cancer
Cancer Research
2024/3/22